GH-axis + recovery stack

Follistatin + Pentadeca Arginate (PDA) stack

A research-context overview of stacking Follistatin with Pentadeca Arginate (PDA): the rationale, complementary benefits, side-effect overlap, and pharmacokinetic considerations. Educational only — never a recommendation.

Why this stack?

Pairing a Performance peptide like Follistatin with a Recovery peptide like Pentadeca Arginate (PDA) is one of the most common stack archetypes in the research literature. The Performance compound drives the GH/IGF-1 axis or anabolic signaling; the Recovery compound shortens the soft-tissue and inflammation tax of training, letting the anabolic signal land on healthier tissue. The two work on independent pathways, so timing concerns are minimal — most researchers dose them on separate clocks.

Performance

Follistatin

Muscle Builder.

Key benefits

  • Inhibits myostatin
  • Increases muscle mass
  • Strength gains

Side effects to watch

  • Tendon stress
  • Joint pain
Reference dose
100 mcg · Daily (10-30 days)
Recovery

Pentadeca Arginate (PDA)

Arginate-salt analog of BPC-157 developed for improved injection stability and tissue repair.

Key benefits

  • Tendon and ligament healing
  • Better stability than BPC-157 acetate
  • Anti-inflammatory

Side effects to watch

  • Injection-site irritation
  • Limited human trial data
Reference dose
250-500 mcg · 1-2x daily SC

Half-life considerations

Reference half-life data for one or both of these compounds is not in our table — see the individual peptide profiles for cited PK ranges.

Profile
Follistatin
Profile
Pentadeca Arginate (PDA)
Compare
Follistatin vs Pentadeca Arginate (PDA)

Educational use only

This calculator is provided for research and educational purposes. Outputs are derived from the values you enter. Always verify your math and consult a licensed physician before acting on any result.